Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from Wednesday, July 01, 2026, until 48 hours after the unaudited financial results for the quarter ending June 30, 2026, are made public. The specific date for the board meeting to consider these results will be communicated later. This measure is standard practice to prevent potential insider trading ahead of financial disclosures.

Niva Bupa Health Insurance Company Ltd announced the appointment of Mr. Ashwani Bhatia as an Additional Director in the capacity of Non-executive, Independent Director, effective June 03, 2026, for a term of five years, subject to shareholder approval. This appointment follows the resignation of Mr. Milind Gajanan Barve, who stepped down as Independent Director and Chairman of the Board due to health reasons, effective June 02, 2026. Mr. Bhatia will also assume the role of Chairperson of the Board, pending IRDAI approval. The company confirmed Mr. Bhatia is not debarred from directorship.

Niva Bupa Health Insurance Company Ltd announced the resignation of Mr. Milind Gajanan Barve as an Independent Director, effective June 02, 2026, due to health reasons. Consequently, he will also step down as Chairman of the Board. The company also approved the appointment of Mr. Ashwani Bhatia as an Additional Director in the capacity of Non-Executive, Independent Director for a five-year term, effective June 03, 2026, subject to shareholder approval. Mr. Bhatia will also assume the role of Chairperson of the Board, pending IRDAI approval.

Niva Bupa Health Insurance has appointed Christopher Patrick Carroll and Siobhan Djihan Moynihan as Additional Non-Executive Directors, effective May 15, 2026, subject to shareholder approval. Ankur Kharbanda is elevated to Executive Director and Deputy CEO, effective May 8, 2026. The company granted 12,251,268 ESOPs to eligible employees under the Niva Bupa Employee Stock Option Plan 2024. Penelope Ruth Dudley and Carlos Antonio Jaureguizar Ruiz-Jarabo resigned as Non-Executive Directors, effective May 8, 2026, due to time constraints.

Niva Bupa Health Insurance has elevated Mr. Ankur Kharbanda, currently Executive Director and CBO, to Executive Director and Deputy Chief Executive Officer, effective May 08, 2026. The Board also approved the appointment of Mr. Christopher Patrick Carroll and Ms. Siobhan Djihan Moynihan as Additional Non-Executive Directors, effective May 15, 2026, subject to shareholder approval. Furthermore, the company granted 12,251,268 ESOPs to eligible employees and noted the resignation of Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo as Non-Executive Directors, effective May 08, 2026.

Niva Bupa Health Insurance Company Ltd's Board of Directors approved the audited financial statements and results for the financial year ended March 31, 2026, based on the Audit Committee's recommendation. The audit report, issued by joint statutory auditors M/s. S.R. Batliboi & Co. LLP and M/s. Nangia & Co. LLP, has an unmodified opinion. The board meeting was held on May 08, 2026, from 04:15 P.M. to 05:00 P.M. (IST).

Niva Bupa Health Insurance reported strong FY26 results with an 80% increase in IFRS Profit After Tax (PAT) to ₹366 crore. The company's Gross Written Premium (GWP) grew by 27% year-on-year, reaching ₹8,586 crore (with 1/n) and ₹9,433 crore (without 1/n). Niva Bupa's market share in the retail health segment improved to 10.1%. The Claim Settlement Ratio also improved to 94.4%, and the Net Promoter Score (NPS) rose to +60. The Combined Insurance Service Ratio (CISR) improved to 101.4% for FY26, with Q4FY26 CISR at 97.4%.

Niva Bupa Health Insurance Company Ltd's Board of Directors approved the audited financial statements and results for the financial year ended March 31, 2026, following the recommendation of the Audit Committee. The audit reports were issued by joint statutory auditors M/s. S.R. Batliboi & Co. LLP and M/s. Nangia & Co. LLP. The CFO confirmed an unmodified opinion in the audit report. The company has applied for forbearance of Expenses of Management (EOM) exceeding the allowable limit with IRDAI, pending approval.

Niva Bupa Health Insurance Company Ltd has announced that its Board of Directors will convene on Friday, May 08, 2026. The primary agenda for this meeting is to consider and approve the Audited Financial Results/Statements for both the quarter and the full financial year ended March 31, 2026. Additionally, the Board will review and approve the Audited IFRS Financial Statements for the financial year ended March 31, 2026. The company also informed that the trading window, which was previously closed, will continue to remain shut until May 10, 2026, inclusive of both days.

Niva Bupa Health Insurance Company Ltd has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the proposed transfer of up to 14,62,02,091 equity shares. The transfer is to be executed by Fettle Tone LLP, an existing investor in the company. This regulatory clearance, dated April 10, 2026, was granted in accordance with Section 6A of the Insurance Act, 1938, and the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024, facilitating a significant change in the company's shareholding structure.